These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7131181)

  • 1. Immunization of cats against shedding of Toxoplasma oocysts.
    Frenkel JK; Smith DD
    J Parasitol; 1982 Oct; 68(5):744-8. PubMed ID: 7131181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of cats with tissue cysts, bradyzoites, and tachyzoites of the T-263 strain of Toxoplasma gondii.
    Freyre A; Choromanski L; Fishback JL; Popiel I
    J Parasitol; 1993 Oct; 79(5):716-9. PubMed ID: 8410543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected oocyst shedding by cats fed Toxoplasma gondii tachyzoites: in vivo stage conversion and strain variation.
    Dubey JP
    Vet Parasitol; 2005 Nov; 133(4):289-98. PubMed ID: 16024176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of monensin on shedding of Toxoplasma oocysts by cats.
    Frenkel JK; Smith DD
    J Parasitol; 1982 Oct; 68(5):851-5. PubMed ID: 7131189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative infectivity of oocysts and bradyzoites of Toxoplasma gondii for intermediate (mice) and definitive (cats) hosts.
    Dubey JP
    Vet Parasitol; 2006 Aug; 140(1-2):69-75. PubMed ID: 16647212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of shedding and re-shedding of Toxoplasma gondii oocysts in experimentally infected cats treated with oral Clindamycin: a preliminary study.
    Malmasi A; Mosallanejad B; Mohebali M; Sharifian Fard M; Taheri M
    Zoonoses Public Health; 2009 Mar; 56(2):102-4. PubMed ID: 18811675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of immunity to shedding of Toxoplasma gondii oocysts by cats.
    Dubey JP
    J Parasitol; 1995 Jun; 81(3):410-5. PubMed ID: 7776126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective vaccine prepared from a new mutant of Toxoplasma gondii for use in cats.
    Frenkel JK; Pfefferkorn ER; Smith DD; Fishback JL
    Am J Vet Res; 1991 May; 52(5):759-63. PubMed ID: 1854103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediation of immunity to Toxoplasma gondii oocyst shedding in cats.
    Davis SW; Dubey JP
    J Parasitol; 1995 Dec; 81(6):882-6. PubMed ID: 8544058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasma gondii: cross-immunity against the enteric cycle.
    Freyre A; Falcón J; Méndez J; Gastell T; Venzal JM
    Exp Parasitol; 2007 Jan; 115(1):48-52. PubMed ID: 16828745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectivity and pathogenicity of Toxoplasma gondii oocysts for cats.
    Dubey JP
    J Parasitol; 1996 Dec; 82(6):957-61. PubMed ID: 8973406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oocyst shedding by cats fed isolated bradyzoites and comparison of infectivity of bradyzoites of the VEG strain Toxoplasma gondii to cats and mice.
    Dubey JP
    J Parasitol; 2001 Feb; 87(1):215-9. PubMed ID: 11227895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tachyzoite-induced life cycle of Toxoplasma gondii in cats.
    Dubey JP
    J Parasitol; 2002 Aug; 88(4):713-7. PubMed ID: 12197119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective activity against oocyst shedding in cats vaccinated with crude rhoptry proteins of the Toxoplasma gondii by the intranasal route.
    Garcia JL; Navarro IT; Biazzono L; Freire RL; da Silva Guimarães Junior J; Cryssafidis AL; Bugni FM; da Cunha IA; Hamada FN; Dias RC
    Vet Parasitol; 2007 Apr; 145(3-4):197-206. PubMed ID: 17296268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the humoral responses of Toxoplasma gondii-infected cats using immunofluorescent assays with tachyzoite, bradyzoite, and gametogenic stages.
    Rush A; Lappin M; Milhausen M
    J Parasitol; 2001 Feb; 87(1):83-9. PubMed ID: 11227907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine.
    Mateus-Pinilla NE; Dubey JP; Choromanski L; Weigel RM
    J Parasitol; 1999 Oct; 85(5):855-60. PubMed ID: 10577720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pyrimethamine and sulfadiazine on the intestinal development of Toxoplasma gondii in cats.
    Sheffield HG; Melton ML
    Am J Trop Med Hyg; 1976 May; 25(3):379-83. PubMed ID: 937628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term antibody responses of cats fed toxoplasma gondii tissue cysts.
    Dubey JP; Lappin MR; Thulliez P
    J Parasitol; 1995 Dec; 81(6):887-93. PubMed ID: 8544059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
    Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
    Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of tissue cyst formation by Toxoplasma gondii in cell cultures using bradyzoites, tachyzoites, and sporozoites.
    Lindsay DS; Dubey JP; Blagburn BL; Toivio-Kinnucan M
    J Parasitol; 1991 Feb; 77(1):126-32. PubMed ID: 1992083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.